Development of a genetic sensor that eliminates p53 deficient cells
TP53 is mutated in many cancers, a system to detect and selectively eliminate p53 mutant cells is an attractive therapeutic strategy. Here, the authors present a genetic sensor that can detect p53 activity and is coupled to the thymidine kinase gene, which can activate the drug Ganciclovir, resultin...
Guardado en:
Autores principales: | Jovan Mircetic, Antje Dietrich, Maciej Paszkowski-Rogacz, Mechthild Krause, Frank Buchholz |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a523286eef224f22b2c54b9effda2530 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The mammalian adult neurogenesis gene ontology (MANGO) provides a structural framework for published information on genes regulating adult hippocampal neurogenesis.
por: Rupert W Overall, et al.
Publicado: (2012) -
Suppression of autophagy promotes fibroblast activation in p53-deficient colorectal cancer cells
por: Takanori Inoue, et al.
Publicado: (2021) -
ISG15 Deficiency Enhances HIV-1 Infection by Accumulating Misfolded p53
por: Edmund Osei Kuffour, et al.
Publicado: (2019) -
Selective therapeutic strategy for p53-deficient cancer by targeting dysregulation in DNA repair
por: Justin Zonneville, et al.
Publicado: (2021) -
Phylointeractomics reconstructs functional evolution of protein binding
por: Dennis Kappei, et al.
Publicado: (2017)